XVOL:BATS-Acruence Active Hedge U.S. Equity ETF (USD)

ETF | Others |

Last Closing

USD 22.2024

Change

-0.07 (-0.31)%

Market Cap

N/A

Volume

6.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-31 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
FBTC Fidelity Wise Origin Bitcoin T..

-3.07 (-3.35%)

USD 19.65B
INDA iShares MSCI India ETF

+0.04 (+0.08%)

USD 9.32B
PAVE Global X U.S. Infrastructure D..

-0.34 (-0.80%)

USD 9.22B
BUFR First Trust Cboe Vest Fund of ..

-0.06 (-0.19%)

USD 6.19B
ARKB ARK 21Shares Bitcoin ETF

-3.45 (-3.29%)

USD 4.54B
BOXX Alpha Architect 1-3 Month Box ..

+0.05 (+0.05%)

USD 4.52B
BBUS JPMorgan BetaBuilders U.S. Equ..

-0.53 (-0.48%)

USD 4.34B
KNG FT Cboe Vest S&P 500® Dividen..

-0.36 (-0.70%)

USD 3.52B
IFRA iShares U.S. Infrastructure ET..

-0.48 (-1.00%)

USD 3.25B
GSUS Goldman Sachs MarketBeta US Eq..

-0.31 (-0.37%)

USD 2.44B

ETFs Containing XVOL

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.07% 86% B+ 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.07% 86% B+ 84% B
Trailing 12 Months  
Capital Gain 17.58% 83% B 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 17.58% 80% B- 80% B-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 0.52% 26% F 25% F
Dividend Return 1.43% 21% F 21% F
Total Return 0.92% 33% F 30% F
Risk Return Profile  
Volatility (Standard Deviation) 12.17% 36% F 41% F
Risk Adjusted Return 11.78% 15% F 16% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials ()

Quarterly Financials ()

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.